A hybrid product combining D-PLLA microspheres with hyaluronic acid, intended for therapies that improve skin structure and quality.

Benefits

• relatively fast clinical improvement,
• long-term skin regeneration,
• natural proportions without excessive volumization.

D-PLLA hybrid products bridge classic biostimulators and regenerative therapies with a more dynamic tissue response.

Clinical indications

Treatments with D-PLLA (including Juvelook® and Lenisna®) may be used in patients:

• with loss of skin quality and density,
• with signs of structural aging,
• after weight loss,
• expecting earlier visible improvement,
• preferring a natural regenerative effect without pronounced volumization.

Most common areas:

• face,
• periocular area,
• selected body areas requiring improved skin quality.

Therapy profile and safety

• individualized treatment planning,
• procedures performed exclusively by a physician,
• D-PLLA can be part of combined therapies,
• short recovery, with possible transient local reactions.

Selection of product and injection technique requires clinical experience and precise medical qualification.

D-PLLA provides faster biostimulatory dynamics, used in modern regenerative medicine in a conscious, patient-tailored way.